These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16369143)

  • 1. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Rothoerl RD; Axmann C; Pina AL; Woertgen C; Brawanski A
    J Neurosurg Anesthesiol; 2006 Jan; 18(1):68-72. PubMed ID: 16369143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
    Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
    Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans.
    Friedman JA; Goerss SJ; Meyer FB; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL; Nichols DA; Atkinson JL; Wijdicks EF
    J Neurosurg; 2002 Aug; 97(2):401-7. PubMed ID: 12186469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.
    Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL
    Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage.
    Romero FR; Cataneo DC; Cataneo AJ
    Acta Cir Bras; 2014 May; 29(5):340-5. PubMed ID: 24863323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytosis and C-Reactive Protein May Predict Development of Secondary Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Buce-Satoba I; Rozkalne D; Mamaja B; Krumina G; Ozolina A
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208646
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage.
    Romero FR; Bertolini Ede F; Figueiredo EG; Teixeira MJ
    Arq Neuropsiquiatr; 2012 Mar; 70(3):202-5. PubMed ID: 22392113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Glucose and Potassium Ratio as Risk Factors for Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Matano F; Fujiki Y; Mizunari T; Koketsu K; Tamaki T; Murai Y; Yokota H; Morita A
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1951-1957. PubMed ID: 31060790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome.
    Faust K; Horn P; Schneider UC; Vajkoczy P
    Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Jeon YT; Lee JH; Lee H; Lee HK; Hwang JW; Lim YJ; Park HP
    J Neurosurg Anesthesiol; 2012 Oct; 24(4):317-24. PubMed ID: 22732721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Mavropoulos JC; McGirt LY; Alexander MJ; Friedman AH; Laskowitz DT; Lynch JR
    J Neurosurg; 2003 Jun; 98(6):1222-6. PubMed ID: 12816268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subarachnoid hemorrhage, cerebral ischemia and endothelin-1].
    Secades JJ; Rubio E; Castellanos JM; de la Rosa MD; Mercadal J; Vilalta J; Catalán R; Galard RM
    Rev Neurol; 2000 Jan 1-15; 30(1):27-34. PubMed ID: 10742992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage.
    Muroi C; Hugelshofer M; Seule M; Tastan I; Fujioka M; Mishima K; Keller E
    Neurosurgery; 2013 Mar; 72(3):367-75; discussion 375. PubMed ID: 23208059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.
    Mocco J; Mack WJ; Kim GH; Lozier AP; Laufer I; Kreiter KT; Sciacca RR; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Sep; 97(3):537-41. PubMed ID: 12296636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage.
    Fujiki Y; Matano F; Mizunari T; Murai Y; Tateyama K; Koketsu K; Kubota A; Kobayashi S; Yokota H; Morita A
    J Neurosurg; 2018 Oct; 129(4):870-875. PubMed ID: 29148905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage.
    Schuss P; Hadjiathanasiou A; Brandecker S; Güresir Á; Vatter H; Güresir E
    J Neurol; 2018 Dec; 265(12):2944-2948. PubMed ID: 30317466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.